US Stock MarketDetailed Quotes
XBIT XBiotech
- 7.420
- +0.610+8.96%
Trading Nov 27 14:08 ET
226.19MMarket Cap-6870P/E (TTM)
7.500High6.810Low65.05KVolume6.830Open6.810Pre Close467.38KTurnover0.33%Turnover RatioLossP/E (Static)30.48MShares9.96052wk High1.18P/B147.28MFloat Cap3.73052wk Low--Dividend TTM19.85MShs Float28.003Historical High--Div YieldTTM10.13%Amplitude1.835Historical Low7.184Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
XBiotech Stock Forum
XBiotech (NASDAQ: XBIT) recently announced promising data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Named 1-BETTER, this study focused on evaluating Natrunix, an anti-interleukin-1alpha antibody, in combination with a well-established chemotherapy regimen comp...
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
XBiotech (NASDAQ: XBIT) announced promising results from its Phase 1/2 trial for advanced pancreatic cancer treatment using Natrunix in combination with a standard chemotherapy regimen. The study, titled 1-BETTER, enrolled 65 subjects who received either the Natrunix combination or a placebo. Key findings include a 28% reduction in signif...
Where can check this information?
If I have 10 share....
Where is the money? 🧐
No comment yet